140 studies found for:    Open Studies | "Colonic Diseases, Functional"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Colonic Diseases, Functional"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Not yet recruiting Peppermint Oil for the Treatment of Irritable Bowel Syndrome: Optimizing Therapeutic Strategies Using Targeted Delivery
Conditions: Irritable Bowel Syndrome;   Abdominal Pain;   Colonic Diseases, Functional
Interventions: Drug: Tempocol-ColoPulse® (Peppermint oil);   Drug: Placebo;   Drug: Tempocol® (Peppermint oil)
2 Recruiting fMRI and Visceral Perception Upon Capsaicin Infusion
Conditions: Irritable Bowel Syndrome;   Colonic Diseases, Functional;   Dyspepsia;   Gastrointestinal Diseases;   Abdominal Pain;   Visceral Pain
Interventions: Other: Capsaicin;   Other: Placebo
3 Recruiting A Study to Evaluate Fecal Microbiota Transplantation Engraftment in IBS
Condition: Irritable Bowel Syndrome
Interventions: Procedure: fecal microbiota transplantation;   Drug: placebo fecal microbiota transplantation;   Procedure: FMT with antibiotic pre-treatment (v1);   Procedure: FMT with antibiotic pre-treatment (v2)
4 Recruiting Microbiome Fructan Metabolism and Symptoms in Childhood IBS
Condition: Irritable Bowel Syndrome (IBS)
Interventions: Other: Fructan;   Other: Maltodextrin
5 Not yet recruiting Genetic Determinism of Epithelial Barrier Defects in Irritable Bowel Syndrome
Condition: Irritable Bowel Syndrome (IBS)
Intervention: Genetic: Analysis on colorectal biopsy
6 Not yet recruiting A Study of the Effect of Linaclotide on Abdominal Girth in Participants With IBS-C
Condition: Irritable Bowel Syndrome Characterized by Constipation
Interventions: Drug: Linaclotide;   Drug: Placebo
7 Not yet recruiting Irritable Bowel Syndrome in Children: Impact of Hypno-analgesia on the Autonomic Balance
Conditions: Child;   Irritable Bowel Syndrome
Intervention:
8 Not yet recruiting A Cross-sectional Study on IBS Subtypes, Chinese Medicine Pattern and Host-gut Microbiota Metabolic Interactions
Condition: Irritable Bowel Syndrome
Intervention:
9 Recruiting Factors Affecting Dissatisfaction to Treatments in Patients With Chronic Constipation and IBS With Constipation
Conditions: Constipation;   Irritable Bowel Syndrome
Intervention:
10 Recruiting Effects of Open-label vs Double-blind Treatment in IBS
Conditions: Irritable Bowel Syndrome;   Placebo Effect;   Placebos;   Peppermint Oil
Interventions: Drug: placebo;   Dietary Supplement: peppermint oil
11 Recruiting A Phase I, Randomized, Placebo-controlled, Double Blind, Repeat Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Gastrointestinal Transit Time and Pharmacodynamic Biomarkers of GSK3179106 in Normal Subjects
Condition: Irritable Bowel Syndrome
Interventions: Drug: GSK3179106;   Drug: Matched Placebo
12 Recruiting Patient-Centred Innovations for Persons With Multimorbidity - Quebec
Conditions: Hypertension;   Depression;   Anxiety;   Musculoskeletal Pain;   Arthritis;   Rheumatoid Arthritis;   Osteoporosis;   Chronic Obstructive Pulmonary Disease (COPD);   Asthma;   Chronic Bronchitis;   Cardiovascular Disease;   Heart Failure;   Stroke;   Transient Ischemic Attacks;   Ulcer;   Gastroesophageal Reflux;   Irritable Bowel;   Crohn's Disease;   Ulcerative Colitis;   Diverticulosis;   Chronic Hepatitis;   Diabetes;   Thyroid Disorder;   Cancer;   Kidney Disease;   Urinary Tract Problem;   Dementia;   Alzheimer's Disease;   Hyperlipidemia;   HIV
Intervention: Behavioral: DIMAC02
13 Not yet recruiting Effect of Fecal Microbiota Transplantation in Irritable Bowel Syndrome
Condition: Irritable Bowel Syndrome
Interventions: Dietary Supplement: FMT capsules;   Dietary Supplement: FMT placebo
14 Recruiting Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of BEKINDA (Ondansetron 12 mg Bimodal Release Tablets) for Diarrhea Predominant Irritable Bowel Syndrome (IBS-D)
Condition: Irritable Bowel Syndrome With Diarrhea
Interventions: Drug: BEKINDA;   Drug: Placebo
15 Recruiting Patient-Centred Innovations for Persons With Multimorbidity - Ontario
Conditions: Hypertension;   Depression;   Anxiety;   Musculoskeletal Pain;   Arthritis;   Rheumatoid Arthritis;   Osteoporosis;   Chronic Obstructive Pulmonary Disease (COPD);   Asthma;   Chronic Bronchitis;   Cardiovascular Disease;   Heart Failure;   Stroke;   Transient Ischemic Attacks;   Ulcer;   Gastroesophageal Reflux;   Irritable Bowel;   Crohn's Disease;   Ulcerative Colitis;   Diverticulosis;   Chronic Hepatitis;   Diabetes;   Thyroid Disorder;   Cancer;   Kidney Disease;   Urinary Tract Problem;   Dementia;   Alzheimer's Disease;   Hyperlipidemia;   HIV;   Multimorbidity
Intervention: Behavioral: TIP / IMPACT Plus Care Coordination
16 Recruiting Food Supplement Physiomanna® Baby in Pediatric Patients
Condition: Irritable Bowel Syndrome Characterized by Constipation
Intervention: Dietary Supplement: Physiomanna® Baby
17 Recruiting Lactibiane Tolérance® in Individuals Suffering From Irritable Bowel Syndrome With Diarrheal Predominance
Condition: Diarrhea Predominant Irritable Bowel Syndrome
Intervention: Dietary Supplement: Lactibiane Tolerance
18 Recruiting A Long-Term Safety Study of Tenapanor for the Treatment of IBS-C
Condition: Constipation Predominant Irritable Bowel Syndrome
Intervention: Drug: Tenapanor
19 Recruiting Evaluation of a Novel Electronic Transanal Irrigation System - Navina™ Smart
Condition: Neurogenic Bowel
Intervention: Device: Navina Smart
20 Recruiting Long Term Safety Study of Plecanatide
Condition: Irritable Bowel Syndrome
Intervention: Drug: Plecanatide

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years